90 related articles for article (PubMed ID: 3531129)
1. Structural modification of Escherichia coli peptidoglycan induced by bicyclomycin.
Pisabarro AG; Cañada FJ; Vázquez D; Arriaga P; Rodríguez-Tébar A
J Antibiot (Tokyo); 1986 Jul; 39(7):914-21. PubMed ID: 3531129
[TBL] [Abstract][Full Text] [Related]
2. Transcription termination factor rho: the site of bicyclomycin inhibition in Escherichia coli.
Zwiefka A; Kohn H; Widger WR
Biochemistry; 1993 Apr; 32(14):3564-70. PubMed ID: 8466900
[TBL] [Abstract][Full Text] [Related]
3. Bicyclomycin sensitivity and resistance affect Rho factor-mediated transcription termination in the tna operon of Escherichia coli.
Yanofsky C; Horn V
J Bacteriol; 1995 Aug; 177(15):4451-6. PubMed ID: 7543478
[TBL] [Abstract][Full Text] [Related]
4. The molecular basis for the mode of action of bicyclomycin.
Kohn H; Widger W
Curr Drug Targets Infect Disord; 2005 Sep; 5(3):273-95. PubMed ID: 16181146
[TBL] [Abstract][Full Text] [Related]
5. Effect of growth rate and cell shape on the peptidoglycan composition in Escherichia coli.
Driehuis F; Wouters JT
J Bacteriol; 1987 Jan; 169(1):97-101. PubMed ID: 3539928
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of action of bicyclomycin.
Tanaka N; Iseki M; Miyoshi T; Aoki H; Imanaka H
J Antibiot (Tokyo); 1976 Feb; 29(2):155-68. PubMed ID: 776917
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antimicrobial evaluation of bicyclomycin analogues.
Williams RM; Armstrong RW; Dung JS
J Med Chem; 1985 Jun; 28(6):733-40. PubMed ID: 4009595
[TBL] [Abstract][Full Text] [Related]
8. Bicyclomycin and dihydrobicyclomycin inhibition kinetics of Escherichia coli rho-dependent transcription termination factor ATPase activity.
Park HG; Zhang X; Moon HS; Zwiefka A; Cox K; Gaskell SJ; Widger WR; Kohn H
Arch Biochem Biophys; 1995 Nov; 323(2):447-54. PubMed ID: 7487110
[TBL] [Abstract][Full Text] [Related]
9. Cloning and sequence analysis of an Escherichia coli gene conferring bicyclomycin resistance.
Bentley J; Hyatt LS; Ainley K; Parish JH; Herbert RB; White GR
Gene; 1993 May; 127(1):117-20. PubMed ID: 8486276
[TBL] [Abstract][Full Text] [Related]
10. Role of the C(6)-hydroxy group in bicyclomycin: synthesis, structure, and chemical, biochemical, and biological properties.
Santillán A; Zhang X; Hardesty J; Widger WR; Kohn H
J Med Chem; 1998 Mar; 41(7):1185-94. PubMed ID: 9544218
[TBL] [Abstract][Full Text] [Related]
11. The bicyclomycin sensitivities of 38 bicyclomycin-resistant mutants of transcription termination protein rho and the location of their mutations support a structural model of rho based on the F(1) ATPase.
Moyse KA; Knight JS; Richardson JP
J Mol Biol; 2000 Sep; 302(3):565-79. PubMed ID: 10986119
[TBL] [Abstract][Full Text] [Related]
12. Structural modifications in the peptidoglycan of Escherichia coli associated with changes in the state of growth of the culture.
Pisabarro AG; de Pedro MA; Vázquez D
J Bacteriol; 1985 Jan; 161(1):238-42. PubMed ID: 3881387
[TBL] [Abstract][Full Text] [Related]
13. Biosynthesis of bicyclomycin. II. Biosynthetic conditions and incorporation of radioactive precursors into bicyclomycin by washed mycelium.
Iseki M; Miyoshi T; Konomi T; Imanaka H
J Antibiot (Tokyo); 1980 May; 33(5):488-93. PubMed ID: 6448830
[TBL] [Abstract][Full Text] [Related]
14. [Inhibition of ureolysis in rat intestine with thiopeptin and bicyclomycin in vivo and in vitro (author's transl)].
Takebe S; Mitsui N; Kobashi K; Hase J
Yakugaku Zasshi; 1981 Dec; 101(12):1124-8. PubMed ID: 7338799
[No Abstract] [Full Text] [Related]
15. Phenotypic characterization of a comprehensive set of bicyclomycin-resistant mutants.
Moyse KA; Knight JS; Richardson JP
Biochim Biophys Acta; 2001 Sep; 1520(3):223-33. PubMed ID: 11566358
[TBL] [Abstract][Full Text] [Related]
16. Semisynthetic bicyclomycin derivatives: preparation and antibacterial evaluation.
Müller BW; Zak O; Kump W; Tosch W; Wacker O
J Antibiot (Tokyo); 1979 Jul; 32(7):689-705. PubMed ID: 541264
[TBL] [Abstract][Full Text] [Related]
17. Lethal synergy involving bicyclomycin: an approach for reviving old antibiotics.
Malik M; Li L; Zhao X; Kerns RJ; Berger JM; Drlica K
J Antimicrob Chemother; 2014 Dec; 69(12):3227-35. PubMed ID: 25085655
[TBL] [Abstract][Full Text] [Related]
18. C(5)-C(5a)-modified bicyclomycins: synthesis, structure, and biochemical and biological properties.
Vincent F; Srinivasan J; Santillán A; Widger WR; Kohn H
J Org Chem; 2001 Apr; 66(7):2251-64. PubMed ID: 11281764
[TBL] [Abstract][Full Text] [Related]
19. Biosynthesis of bicyclomycin. I. Appearance of aerial mycelia negative strains (am-).
Miyoshi T; Iseki M; Konomi T; Imanaka H
J Antibiot (Tokyo); 1980 May; 33(5):480-7. PubMed ID: 7000736
[TBL] [Abstract][Full Text] [Related]
20. Peptidoglycan biosynthesis in stationary-phase cells of Escherichia coli.
Blasco B; Pisabarro AG; de Pedro MA
J Bacteriol; 1988 Nov; 170(11):5224-8. PubMed ID: 3141382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
